Abstract Details
|
Shuichi Suzuki, MD, PhD
(UCI)
PRESENTER |
No disclosure on file |
| No disclosure on file | |
| Ravi Patel, MD, MBA, FAHA (Niva Institute of Neurosciences) | No disclosure on file |
| No disclosure on file | |
| No disclosure on file | |
| Hermelinda Abcede, MD (TeleSpecialists, LLC) | Dr. Abcede has nothing to disclose. |
| Mohammad Shafie, MD (Department of Neurology - University of California, Irvine) | Dr. Shafie has nothing to disclose. |
| Wengui Yu, MD, PhD (UC Irvine, Neurology Dept) | Dr. Yu has nothing to disclose. |
| Steven C. Cramer, MD, FAAN | Dr. Cramer has received personal compensation for serving as an employee of University of California. An immediate family member of Dr. Cramer has received personal compensation for serving as an employee of University of California. Dr. Cramer has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Astellas, Alevian, Bayer, BlueRock Therapeutics, BrainQ, Constant Therapeutics, Medtronic, MicroTransponder, Myomo, Myrobalan, NeuroTrauma Sciences, Simcere, and TRCare. Dr. Cramer has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for MUSC. Dr. Cramer has stock in Constant Therapeutics, Panaxium, and TRCare. The institution of Dr. Cramer has received research support from NIH; PCORI; Veterans Administration. |
| Mark J. Fisher, MD (UCI Medical Center, Dept of Neurology) | The institution of Dr. Fisher has received research support from NIH. |
| No disclosure on file |